OptimizeRx
OPRX
97 hedge funds and large institutions have $155M invested in OptimizeRx in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 38 reducing their positions, and 17 closing their positions.
1,662% more call options, than puts
Call options by funds: $229K | Put options by funds: $13K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
1.16% more ownership
Funds ownership: 69.26% → 70.42% (+1.2%)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
1% less funds holding
Funds holding: 98 → 97 (-1)
14% less capital invested
Capital invested by funds: $180M → $155M (-$24.5M)
37% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$9.04M |
| 2 |
SM
Samjo Management
New York
|
+$2.24M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.26M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$858K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$646K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.48M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$1.92M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.65M |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
-$1.38M |
| 5 |
Morgan Stanley
New York
|
-$1.19M |
OPRX Hedge Fund Activity: Q1 2024 in Review
97 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2024, worth a combined $155M — down 14% from $180M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of OPRX and 16 opened new positions — a net loss of 1 holder — while 38 trimmed existing stakes and 24 added.
The largest buyer was Divisadero Street Capital Management, adding an estimated $9.04M. The largest seller was Kennedy Capital Management, cutting an estimated $2.48M.
- 97 institutional investors held OptimizeRx (OPRX) as of Q1 2024, down from 98 in Q4 2023.
- Funds reported $155M of OptimizeRx stock for Q1 2024, down 14% quarter-over-quarter.
- 16 funds opened new OptimizeRx positions in Q1 2024 and 17 closed out, a net change of -1 holder.
- The largest OptimizeRx buyer in Q1 2024 was Divisadero Street Capital Management, an estimated $9.04M added.
- The largest OptimizeRx seller in Q1 2024 was Kennedy Capital Management, an estimated $2.48M sold.
Based on aggregated 13F filings for Q1 2024.